Senses

Eyenuk To Provide Artificial Intelligence (AI) Eye Screening to Thousands of Italians Through Collaboration With Ambrosian Ophthalmic Center in February

Retrieved on: 
Thursday, February 7, 2019
Technology, Software, Health, Optical, Diabetes, Organ systems, RTT, Diabetes mellitus, Retina, Senses, Perception, Ophthalmology, Diabetic retinopathy

The collaboration between the Ambrosian Ophthalmic Center (CAMO), San Raffaele Hospital and Eyenuk is sponsored by the Italian Ministry of Health, the city of Milan and the Italian Ophthalmology Society.

Key Points: 
  • The collaboration between the Ambrosian Ophthalmic Center (CAMO), San Raffaele Hospital and Eyenuk is sponsored by the Italian Ministry of Health, the city of Milan and the Italian Ophthalmology Society.
  • DR is a complication of diabetes and the main cause of vision impairment and blindness among working-age adults.
  • It occurs when high blood sugar levels lead to damage in the blood vessels of the retina, the light-sensitive tissue at the back of the eye.
  • Annual eye screening is recommended for people living with diabetes since DR can progress silently without any perceptible symptoms or vision deterioration.

Intraocular Lens Market to Grow Swiftly Owing to Rising Prevalence of Eye Diseases and Diabetes: Radiant Insights, Inc.

Retrieved on: 
Thursday, February 7, 2019
Medical specialties, Medicine, Vision, Senses, Corrective lenses, Eye surgery, Eye, Ophthalmology, Intraocular lens, IOL, Glued IOL, Multifocal intraocular lens

Intraocular Lens (IOL) Market may be explored by product type as Accommodative IOL, Multifocal IOL, Monofocal IOL and Toric IOL.

Key Points: 
  • Intraocular Lens (IOL) Market may be explored by product type as Accommodative IOL, Multifocal IOL, Monofocal IOL and Toric IOL.
  • The "Monofocal IOLs" segment led the Intraocular Lens (IOL) Market in 2016 and is anticipated to maintain its dominance by 2022.
  • Access 119 page research report with TOC on "Intraocular Lens (IOL) Market" available with Radiant Insights, Inc. @ https://www.radiantinsights.com/research/global-intraocular-lens-iol-mar...
    The report covers forecast and analysis for the intraocular lens market on a global and regional level.
  • Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global intraocular lens market.

Intraocular Lens Market to Grow Swiftly Owing to Rising Prevalence of Eye Diseases and Diabetes: Radiant Insights, Inc.

Retrieved on: 
Thursday, February 7, 2019
Medical specialties, Medicine, Vision, Senses, Corrective lenses, Eye surgery, Eye, Ophthalmology, Intraocular lens, IOL, Glued IOL, Multifocal intraocular lens

Intraocular Lens (IOL) Market may be explored by product type as Accommodative IOL, Multifocal IOL, Monofocal IOL and Toric IOL.

Key Points: 
  • Intraocular Lens (IOL) Market may be explored by product type as Accommodative IOL, Multifocal IOL, Monofocal IOL and Toric IOL.
  • The "Monofocal IOLs" segment led the Intraocular Lens (IOL) Market in 2016 and is anticipated to maintain its dominance by 2022.
  • Access 119 page research report with TOC on "Intraocular Lens (IOL) Market" available with Radiant Insights, Inc. @ https://www.radiantinsights.com/research/global-intraocular-lens-iol-mar...
    The report covers forecast and analysis for the intraocular lens market on a global and regional level.
  • Relevantly, the report and company profiles specify the key drivers that are impacting the demand in global intraocular lens market.

Kugler Vision Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

Retrieved on: 
Tuesday, February 5, 2019
Health, Clinical trials, Medical devices, Optical, General Health, Senses, Perception, Vision, Medical specialties, Eye, Ophthalmology, Corrective lenses, Intraocular lens, Cataract, IOL

at Kugler Vision in Omaha, Neb., is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.

Key Points: 
  • at Kugler Vision in Omaha, Neb., is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.
  • We look forward to evaluating the IC-8 lens and its ability to provide cataract patients with an uninterrupted range of vision.
  • Dr. Kugler will be one of a select group of clinical investigators across the United States for the IC-8 lens study .
  • If you are interested in becoming a volunteer participant in the IC-8 lens clinical study, please contact Jolene Palmquist at Kugler Vision at (402) 558-2211 or at [email protected] .

Johnson & Johnson Vision Announces Availability in Europe of TECNIS Eyhance IOL, a Next-Generation Monofocal Intraocular Lens for Patients with Cataracts

Retrieved on: 
Monday, February 4, 2019
Senses, Perception, Vision, Ophthalmology, Medical specialties, Eye, Corrective lenses, Intraocular lens, IOL, Johnson & Johnson, Cataract, Abbott Medical Optics

This next-generation monofocal intraocular lens (IOL) allows patients to experience high-quality vision at both intermediate and far distances.

Key Points: 
  • This next-generation monofocal intraocular lens (IOL) allows patients to experience high-quality vision at both intermediate and far distances.
  • "With the availability of TECNIS Eyhance IOL in Europe, we are proud to deliver another meaningful solution for patients with cataracts," said Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision3.
  • TECNIS, TECNIS Eyhance and TECNIS Symfony are trademarks of Johnson & Johnson Surgical Vision, Inc. Johnson & Johnson Surgical Vision, Inc. 2019.
  • 1 TECNIS Eyhance IOL - Product monograph EMEA 2019, table 4.1 SC2019CT4002
    2Johnson & Johnson Surgical Vision, Inc.
    3 Employed by Johnson & Johnson Surgical Vision, Inc.
    4Data on File, Johnson & Johnson Surgical Vision, Inc. 2018.

GenSight Biologics reports topline results at Week 48 of the RESCUE Phase III clinical trial of GS010 in subjects within six months of visual loss onset due to Leber Hereditary Optic Neuropathy (LHON)

Retrieved on: 
Monday, February 4, 2019
Health, Biotechnology, Clinical trials, Genetics, Pharmaceutical, Other Health, Visual system, Organ systems, Senses, Perception, RTT, Blindness

These subjects received GS010 in one eye and a sham injection in the other eye, with drug treatment randomized between best- and worst-affected eyes.

Key Points: 
  • These subjects received GS010 in one eye and a sham injection in the other eye, with drug treatment randomized between best- and worst-affected eyes.
  • At Week 48, change from baseline for GS010-treated eyes was -19 ETDRS letters equivalent, while that for sham-treated eyes -20 ETDRS letters equivalent.
  • As RESCUE subjects had vision loss for 0 to 6 months before treatment, assumed average time for cohort from visual loss to treatment plotted at 3 months (12 weeks).
  • As RESCUE subjects had vision loss for 0 to 6 months before treatment, assumed average time for cohort from visual loss to treatment plotted at 3 months (12 weeks).

Haag-Streit Academy to Offer Free 'Visual Field Digest' at 'Gold Standard' Perimetry Course

Retrieved on: 
Thursday, January 24, 2019
Ophthalmology, Senses, Vision, Light, Visual field, Visual system, Digest

HARLOW, England, Jan. 24, 2019 /PRNewswire/ -- Haag-Streit Academy will offer afree copy of the 'Visual Field Digest - A guide to perimetry and the Octopus perimeter'to all delegates who attend the upcoming 'Gold Standard' Perimetry Course.

Key Points: 
  • HARLOW, England, Jan. 24, 2019 /PRNewswire/ -- Haag-Streit Academy will offer afree copy of the 'Visual Field Digest - A guide to perimetry and the Octopus perimeter'to all delegates who attend the upcoming 'Gold Standard' Perimetry Course.
  • The course is due to be held at the Royal College of Ophthalmologists on Tuesday 26thFebruary 2019.
  • Written by six experts in the field of perimetry, the digest is an invaluable resource for clinicians, residents, students, researchers and visual field examiners alike.
  • Limited spaces on the Gold-Standard Perimetry course are available, so book now to avoid disappointment.

Midwest Vision Research Foundation at Pepose Vision Institute Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

Retrieved on: 
Thursday, January 24, 2019
Surgery, Health, Clinical trials, Medical devices, Optical, Senses, Perception, Vision, Light, Eye, Ophthalmology, Intraocular lens, Cataract, IOL, Vision Institute

D, Mujtaba Qazi, MD, and Jonathan Crews, DO with Midwest Vision Research Foundation at Pepose Vision Institute in St. Louis, Mo., are participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.

Key Points: 
  • D, Mujtaba Qazi, MD, and Jonathan Crews, DO with Midwest Vision Research Foundation at Pepose Vision Institute in St. Louis, Mo., are participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.
  • That it is why it is so exciting for me and the entire Pepose Vision team to be part of the AcuFocus IC-8 lens clinical study.
  • The Midwest Vision Research Foundation at Pepose Vision Institute is now enrolling patients that meet the study eligibility criteria.
  • If you are interested in becoming a volunteer participant in the IC-8 lens clinical study, please contact Lee Collier at the Midwest Vision Research Foundation at Pepose Vision Institute at (636) 534-5126 or at [email protected] .

Americans’ Financial Satisfaction Drops for the First Time in 2 Years: AICPA Index

Retrieved on: 
Thursday, January 24, 2019
Professional services, Accounting, Banking, Finance, Perception, Senses, Acute pain, Nociception, Pain, Suffering, Index, Nervous system

With a reading of 30.9, the AICPAs Q4 2018 Personal Financial Satisfaction Index (PFSi) declined for the first time in seven quarters, ending its five-quarter run of consecutive record highs.

Key Points: 
  • With a reading of 30.9, the AICPAs Q4 2018 Personal Financial Satisfaction Index (PFSi) declined for the first time in seven quarters, ending its five-quarter run of consecutive record highs.
  • View the full release here: https://www.businesswire.com/news/home/20190124005017/en/
    Q4 2018 PFSi Infographic (Graphic: Business Wire)
    The PFSi is calculated as the Personal Financial Pleasure Index (Pleasure Index) minus the Personal Financial Pain Index (Pain Index), with positive readings signaling that Americans are feeling more financial pleasure than pain.
  • The Pain Index, at 39.3, saw three factors decrease from the previous quarter, combining to drop the index 2.6 points.
  • It is calculated as the difference between the Personal Financial Pleasure Index and the Personal Financial Pain Index.